Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Larimar Therapeutics Inc (NASDAQ: LRMR) was $4.04 for the day, down -6.26% from the previous closing price of $4.31. In other words, the price has decreased by -$6.26 from its previous closing price. On the day, 1.05 million shares were traded. LRMR stock price reached its highest trading level at $4.415 during the session, while it also had its lowest trading level at $4.01.
Ratios:
Our analysis of LRMR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.46 and its Current Ratio is at 5.46. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Truist on January 29, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
On October 16, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26.
On October 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $22.Wedbush initiated its Outperform rating on October 03, 2024, with a $22 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 31 ’25 when Flynn James E bought 9,375,000 shares for $3.20 per share. The transaction valued at 30,000,000 led to the insider holds 9,538,945 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 345785184 and an Enterprise Value of 211875184.
Stock Price History:
The Beta on a monthly basis for LRMR is 1.14, which has changed by -0.47803617 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, LRMR has reached a high of $9.50, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is -3.01%, while the 200-Day Moving Average is calculated to be 26.65%.
Shares Statistics:
LRMR traded an average of 2.66M shares per day over the past three months and 1510190 shares per day over the past ten days. A total of 64.03M shares are outstanding, with a floating share count of 48.64M. Insiders hold about 43.17% of the company’s shares, while institutions hold 42.04% stake in the company. Shares short for LRMR as of 1760486400 were 8816753 with a Short Ratio of 3.31, compared to 1757894400 on 7653965. Therefore, it implies a Short% of Shares Outstanding of 8816753 and a Short% of Float of 15.49.
Earnings Estimates
The dynamic stock of Larimar Therapeutics Inc (LRMR) is currently attracting attention from 8.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.36 and low estimates of -$0.49.
Analysts are recommending an EPS of between -$1.57 and -$1.76 for the fiscal current year, implying an average EPS of -$1.68. EPS for the following year is -$1.67, with 7.0 analysts recommending between -$1.18 and -$2.22.
